ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.787,08
0,06%
S&P 500
5.509,01
0,62%
US Dollar vs BRL
5,6773
0,36%
Bitcoin
62.010,35
-1,34%
Brent Oil
86,445
-0,10%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. F star Therapeutics Inc (FSTX)

  7. F star Therapeutics Inc (FSTX) Notícias

FSTX

F star Therapeutics (FSTX)

F star Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FSTX
DataHoraFonteTítuloCódigoCompanhia
17/03/202317:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FSTXF star Therapeutics Inc
14/03/202307:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FSTXF star Therapeutics Inc
09/03/202311:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FSTXF star Therapeutics Inc
09/03/202310:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FSTXF star Therapeutics Inc
09/03/202310:38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FSTXF star Therapeutics Inc
09/03/202310:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FSTXF star Therapeutics Inc
09/03/202310:22Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FSTXF star Therapeutics Inc
09/03/202310:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FSTXF star Therapeutics Inc
07/03/202311:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FSTXF star Therapeutics Inc
14/02/202318:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FSTXF star Therapeutics Inc
10/11/202218:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FSTXF star Therapeutics Inc
09/09/202217:22Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:FSTXF star Therapeutics Inc
09/09/202217:16Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:FSTXF star Therapeutics Inc
15/07/202207:16TipRanksH.C. Wainwright Sticks to Its Hold Rating for F-star Therapeutics (FSTX)NASDAQ:FSTXF star Therapeutics Inc
07/07/202212:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:FSTXF star Therapeutics Inc
07/07/202207:05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FSTXF star Therapeutics Inc
24/06/202210:52TipRanksSino Biopharmaceutical to Acquire F-star Therapeutics SharesNASDAQ:FSTXF star Therapeutics Inc
23/06/202217:59Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FSTXF star Therapeutics Inc
23/06/202216:39Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:FSTXF star Therapeutics Inc
17/05/202207:15TipRanksH.C. Wainwright Thinks F-star Therapeutics’ Stock is Going to RecoverNASDAQ:FSTXF star Therapeutics Inc
12/05/202204:35TipRanksF-star Therapeutics (FSTX) Receives a Buy from SVB SecuritiesNASDAQ:FSTXF star Therapeutics Inc
02/05/202212:15TipRanksLeerink Partners Thinks F-star Therapeutics’ Stock is Going to RecoverNASDAQ:FSTXF star Therapeutics Inc
27/04/202217:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FSTXF star Therapeutics Inc
22/04/202217:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FSTXF star Therapeutics Inc
15/03/202208:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FSTXF star Therapeutics Inc
01/03/202220:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FSTXF star Therapeutics Inc
20/01/202210:00GlobeNewswire Inc.F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3NASDAQ:FSTXF star Therapeutics Inc
07/01/202210:00GlobeNewswire Inc.F-star Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:FSTXF star Therapeutics Inc
05/01/202210:00GlobeNewswire Inc.F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology CollaborationNASDAQ:FSTXF star Therapeutics Inc
07/12/202111:05GlobeNewswire Inc.F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021NASDAQ:FSTXF star Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FSTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
HAGA3
HAGA ON
BOV
OIBR3
OI ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
PRIO3
PETRORIO ON
BOV
AMAR3
LOJAS MARISA ON
BOV
AZEV4
AZEVEDO PN
BOV
NGRD3
Neogrid Participacoes ON
BOV
MEAL3
IMC S/A ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
AZUL4
AZUL PN
BOV
VVEO3
CM Hospitalar ON
BOV
GOLL4
GOL PN
BOV
TECN3
TECHNOS ON
BOV
PINE4
PINE PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados